The applications of pharmacogenomics to neurological disorders

Keyphrases

• Pharmacogenomics 100%
• Neurological Disorders 100%
• Neurodegenerative Diseases 66%
• Recent Advances 33%
• Genomic Technologies 33%
• Alzheimer's Disease 33%
• Personalized Medicine 33%
• Protease 33%
• Parkinson's Disease 33%
• Schizophrenia 33%
• Mitochondrial Function 33%
• Psychiatric Disorders 33%
• Neurodegeneration 33%
• Mental Illness 33%
• DNA Repair Capacity 33%
• Distinct Mechanism 33%
• Autism Spectrum Disorder 33%
• Attention Deficit Hyperactivity Disorder 33%
• Calcium Homeostasis 33%
• Neurogenesis 33%
• Cerebral Ischemic Stroke 33%
• Putative Drug Targets 33%
• Obsessive-compulsive Disorder 33%

Neuroscience

• Neurodegenerative Disorder 100%
• Neurological Disorder 100%
• Alzheimer's Disease 50%
• Pervasive Developmental Disorder 50%
• Proteinase 50%
• Parkinson's Disease 50%
• Dementia Praecox 50%
• Neurodegeneration 50%
• Brain Ischemia 50%
• Reactive Oxygen Species 50%
• Attention Deficit Hyperactivity Disorder 50%
• Neurogenesis 50%
• Mitochondrial Function 50%
• Obsessive-Compulsive Disorder 50%
• DNA Repair 50%